Parametric Portfolio Associates’s Enanta Pharmaceuticals ENTA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$5.69M Sell
79,959
-10,303
-11% -$733K ﹤0.01% 1760
2021
Q4
$6.75M Buy
90,262
+11,837
+15% +$885K ﹤0.01% 1658
2021
Q3
$4.46M Buy
78,425
+16,639
+27% +$945K ﹤0.01% 1912
2021
Q2
$2.72M Sell
61,786
-44,756
-42% -$1.97M ﹤0.01% 2256
2021
Q1
$5.26M Buy
106,542
+55,936
+111% +$2.76M ﹤0.01% 2130
2020
Q4
$2.13M Buy
50,606
+2,780
+6% +$117K ﹤0.01% 2610
2020
Q3
$2.19M Buy
47,826
+12,055
+34% +$552K ﹤0.01% 2461
2020
Q2
$1.8M Sell
35,771
-394
-1% -$19.8K ﹤0.01% 2561
2020
Q1
$1.86M Buy
36,165
+9,657
+36% +$497K ﹤0.01% 2426
2019
Q4
$1.64M Sell
26,508
-3,543
-12% -$219K ﹤0.01% 2816
2019
Q3
$1.81M Buy
30,051
+508
+2% +$30.5K ﹤0.01% 2694
2019
Q2
$2.49M Sell
29,543
-2,489
-8% -$210K ﹤0.01% 2519
2019
Q1
$3.06M Sell
32,032
-3,165
-9% -$302K ﹤0.01% 2359
2018
Q4
$2.49M Buy
35,197
+5,860
+20% +$415K ﹤0.01% 2432
2018
Q3
$2.51M Sell
29,337
-12,009
-29% -$1.03M ﹤0.01% 2552
2018
Q2
$4.79M Buy
41,346
+9,388
+29% +$1.09M ﹤0.01% 2000
2018
Q1
$2.59M Buy
31,958
+8,172
+34% +$661K ﹤0.01% 2436
2017
Q4
$1.4M Buy
23,786
+7,163
+43% +$420K ﹤0.01% 2839
2017
Q3
$778K Buy
16,623
+3,847
+30% +$180K ﹤0.01% 3172
2017
Q2
$460K Buy
12,776
+922
+8% +$33.2K ﹤0.01% 3408
2017
Q1
$365K Buy
11,854
+1,989
+20% +$61.2K ﹤0.01% 3351
2016
Q4
$330K Sell
9,865
-1,764
-15% -$59K ﹤0.01% 3376
2016
Q3
$309K Sell
11,629
-4,545
-28% -$121K ﹤0.01% 3404
2016
Q2
$357K Sell
16,174
-6,705
-29% -$148K ﹤0.01% 3371
2016
Q1
$672K Buy
22,879
+5,631
+33% +$165K ﹤0.01% 3171
2015
Q4
$570K Buy
17,248
+331
+2% +$10.9K ﹤0.01% 3158
2015
Q3
$611K Sell
16,917
-2,287
-12% -$82.6K ﹤0.01% 2616
2015
Q2
$864K Buy
19,204
+6,076
+46% +$273K ﹤0.01% 2907
2015
Q1
$402K Sell
13,128
-1,508
-10% -$46.2K ﹤0.01% 3400
2014
Q4
$744K Sell
14,636
-31,177
-68% -$1.58M ﹤0.01% 3006
2014
Q3
$1.81M Buy
45,813
+39,351
+609% +$1.56M ﹤0.01% 2173
2014
Q2
$278K Buy
+6,462
New +$278K ﹤0.01% 3559